EUVIMEDEUVIMED entdecken
Open Access

Expression and prognostic significance of CRKL in clear cell renal cell carcinoma

Jinxia Wang, Ye Yang, Xiao Yuan, Weichen Wang

American Journal of Clinical and Experimental Immunology · 2026 · 15 (3) · 228-243

DOI: 10.62347/briw9536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2026. Verfasst von Jinxia Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Binzhou Medical University Hospital Binzhou 256603, Shandong, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is an aggressive kidney malignancy with limited prognostic biomarkers. CRKL has been implicated in cancer progression, but its prognostic value and immune associations in ccRCC remain unclear. Using TCGA, GEO, and UALCAN databases, we analyzed CRKL expression. Kaplan-Meier and multivariate Cox regression assessed survival; TIMER and TISIDB evaluated immune infiltration; LinkedOmics databases and GSEA identified enriched pathways. CRKL was significantly overexpressed in ccRCC tissues at both mRNA and protein levels. Surprisingly, high CRKL expression was associated with better overall survival (OS), disease-specific survival (DSS), progression-free interval (PFI), and disease free survival (DFS). Multivariate Cox analysis identified CRKL as an independent favorable prognostic factor (OS: HR = 0.469, 95% CI: 0.302-0.729, P < 0.001). CRKL positively correlated with immune cell infiltration and immune-related pathways. In conclusion, CRKL is overexpressed in ccRCC, paradoxically, higher expression predicts better prognosis and is associated with immune-active tumor microenvironment features. These findings suggest that the favorable prognosis associated with CRKL may be attributable to its immunomodulatory role within the tumor microenvironment, highlighting its potential as a novel prognostic biomarker for ccRCC.

Schlagwörter

Stichwörter der Autor:innen

CRKLbioinformaticsclear cell renal cell carcinoma (ccRCC)immune infiltrationprognosis

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Binzhou Medical University Hospital Binzhou 256603, Shandong, China.
  • Department of Clinical Microbiology and Immunology Teaching and Research, Binzhou Medical University Binzhou 256603, Shandong, China.
  • Department of Clinical Biochemistry and Molecular Biology Teaching and Research, Binzhou Medical University Binzhou 256603, Shandong, China.

Zitieren

APA

Wang, J., Yang, Y., Yuan, X., & Wang, W. (2026). Expression and prognostic significance of CRKL in clear cell renal cell carcinoma. American Journal of Clinical and Experimental Immunology, 15(3), 228-243. https://doi.org/10.62347/briw9536

Vancouver

Wang J, Yang Y, Yuan X, Wang W. Expression and prognostic significance of CRKL in clear cell renal cell carcinoma. American Journal of Clinical and Experimental Immunology. 2026;15(3):228-243. doi:10.62347/briw9536

BibTeX
@article{Wang2026,
  author = {Wang, Jinxia and Yang, Ye and Yuan, Xiao and Wang, Weichen},
  title = {Expression and prognostic significance of CRKL in clear cell renal cell carcinoma},
  journal = {American Journal of Clinical and Experimental Immunology},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {228--243},
  doi = {10.62347/briw9536}
}
Kostenlos starten →